Journal of Clinical Oncology

Phase II study of pembrolizumab plus capecitabine and bevacizumab in microsatellite stable (MSS) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology

Andrea Grace Bocobo, Renee Wang, Spencer Behr, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Lawrence Fong, Bridget P Keenan, Wesley Allen Kidder, Andrew H. Ko, Kanti Pallav Kolli, Megan Kennedy, Angela Laffan, Sorbarikor Piawah, Marin Pollak, Gabriel Schwartz, Julia Whitman, Li Zhang, Katherine Van Loon, Chloe Evelyn Atreya

Optimizing pancreatic cancer management with next generation imaging and liquid biopsy (CHANGE-PDAC).

Journal of Clinical Oncology

Erica S Tsang, Eric Andrew Collisson, Zhen J. Wang, Sorbarikor Piawah, Taylor Sanchez, Margaret A. Tempero, Andrew H. Ko

The marginal diagnostic benefit of pancreatic cancer molecular profiling after germline testing.

Journal of Clinical Oncology

Evan Justin Walker, Amie Blanco, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Margaret A. Tempero, Andrew H. Ko

Investigating tumor molecular profiling as a possible contributor to racial/ethnic disparities in pancreatic cancer.

Journal of Clinical Oncology

Evan Justin Walker, Sorbarikor Piawah, Ann Griffin, Julia C. Carnevale, Pelin Cinar, Eric Andrew Collisson, Margaret A. Tempero, Andrew H. Ko

Rural and urban disparities based on zip code of residence: Analyses of 834 and 2,159 patients in NCCTG N9741 and CALGB 80405 (Alliance) trials respectively.

Journal of Clinical Oncology

Midhun Malla, Lucas J. Huebner, Sorbarikor Piawah, Heinz-Josef Lenz, Charles David Blanke, Jeffrey A. Meyerhardt, Eileen Mary O'Reilly, Qian Shi, Alan P. Venook, Richard M. Goldberg

A regulatory program that promotes metastasis in colorectal cancer (CRC) through modulation of mRNA stability.

Journal of Clinical Oncology

Hani Goodarzi, Robert S. Warren, Johnny Yu, Lisa Fish

Pages